Side-by-side comparison of AI visibility scores, market position, and capabilities
Springfield MO auto parts retail (NASDAQ: ORLY) at record $16.71B FY2024 sales (+6%); 32 consecutive years comp growth, 6,200+ stores, professional + DIY dual-market competing with AutoZone and Advance Auto.
O'Reilly Automotive, Inc. is a Springfield, Missouri-based specialty retailer and supplier of automotive aftermarket parts, tools, supplies, equipment, and accessories — publicly traded on NASDAQ (NASDAQ: ORLY) as an S&P 500 Consumer Discretionary component — operating approximately 6,200 stores across 48 states, Puerto Rico, Canada, and Mexico, serving both do-it-yourself (DIY) consumers who repair their own vehicles and professional service providers (DIFM, Do-It-For-Me — auto repair shops, body shops, dealerships) through approximately 89,000 team members. In fiscal year 2024, O'Reilly reported record full-year sales of $16.71 billion (+6% year-over-year) and net income of $2.39 billion (+2%), marking 32 consecutive years of comparable store sales growth — an unbroken streak through multiple recessions, pandemic disruptions, and consumer spending cycles. Fourth quarter comparable store sales grew 4.4% driven by solid growth in both professional and DIY segments, with 198 net new stores opened during 2024. CEO Brad Beckham, who took over in March 2023 from Greg Johnson, continues the operational discipline that has made O'Reilly the most consistently profitable auto parts retailer in the US — maintaining the dual-market strategy that simultaneously serves professional mechanics who need parts immediately (same-day delivery from O'Reilly's 200+ distribution centers to the repair shop) and weekend DIY customers who replace their own brakes, oil filters, and batteries with O'Reilly team member assistance.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.